182 related articles for article (PubMed ID: 22344671)
1. Chromosome 17q25 genes, RHBDF2 and CYGB, in ovarian cancer.
Wojnarowicz PM; Provencher DM; Mes-Masson AM; Tonin PN
Int J Oncol; 2012 Jun; 40(6):1865-80. PubMed ID: 22344671
[TBL] [Abstract][Full Text] [Related]
2. Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer.
Xinarianos G; McRonald FE; Risk JM; Bowers NL; Nikolaidis G; Field JK; Liloglou T
Hum Mol Genet; 2006 Jul; 15(13):2038-44. PubMed ID: 16698880
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.
Presneau N; Dewar K; Forgetta V; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2005 Jul; 43(3):141-54. PubMed ID: 15937959
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel variant, 1484delG in the 3'UTR of H3F3B, a member of the histone 3B replacement family, in ovarian tumors.
Presneau N; Shen Z; Provencher D; Mes-Masson AM; Tonin PN
Int J Oncol; 2005 Jun; 26(6):1621-7. PubMed ID: 15870878
[TBL] [Abstract][Full Text] [Related]
5. Cytoglobin has bimodal: tumour suppressor and oncogene functions in lung cancer cell lines.
Oleksiewicz U; Liloglou T; Tasopoulou KM; Daskoulidou N; Bryan J; Gosney JR; Field JK; Xinarianos G
Hum Mol Genet; 2013 Aug; 22(16):3207-17. PubMed ID: 23591990
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer.
Manderson EN; Birch AH; Shen Z; Mes-Masson AM; Provencher D; Tonin PN
Int J Gynecol Cancer; 2009 May; 19(4):513-25. PubMed ID: 19509545
[TBL] [Abstract][Full Text] [Related]
7. FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcome.
Quinn MC; Wojnarowicz PM; Pickett A; Provencher DM; Mes-Masson AM; Davis EC; Tonin PN
Int J Oncol; 2013 Mar; 42(3):912-20. PubMed ID: 23354471
[TBL] [Abstract][Full Text] [Related]
8. Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene.
Shivapurkar N; Stastny V; Okumura N; Girard L; Xie Y; Prinsen C; Thunnissen FB; Wistuba II; Czerniak B; Frenkel E; Roth JA; Liloglou T; Xinarianos G; Field JK; Minna JD; Gazdar AF
Cancer Res; 2008 Sep; 68(18):7448-56. PubMed ID: 18794132
[TBL] [Abstract][Full Text] [Related]
9. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
[TBL] [Abstract][Full Text] [Related]
10. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
[TBL] [Abstract][Full Text] [Related]
11. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
12. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.
Birch AH; Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
Mol Carcinog; 2008 Jan; 47(1):56-65. PubMed ID: 17620309
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer.
Wu Y; Zhang X; Lin L; Ma XP; Ma YC; Liu PS
Asian Pac J Cancer Prev; 2014; 15(3):1171-6. PubMed ID: 24606436
[TBL] [Abstract][Full Text] [Related]
15. Relationship between promoter methylation & tissue expression of MGMT gene in ovarian cancer.
Shilpa V; Bhagat R; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L
Indian J Med Res; 2014 Nov; 140(5):616-23. PubMed ID: 25579142
[TBL] [Abstract][Full Text] [Related]
16. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
Benoît MH; Hudson TJ; Maire G; Squire JA; Arcand SL; Provencher D; Mes-Masson AM; Tonin PN
Int J Oncol; 2007 Jan; 30(1):5-17. PubMed ID: 17143508
[TBL] [Abstract][Full Text] [Related]
17. Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors.
Russell SE; McIlhatton MA; Burrows JF; Donaghy PG; Chanduloy S; Petty EM; Kalikin LM; Church SW; McIlroy S; Harkin DP; Keilty GW; Cranston AN; Weissenbach J; Hickey I; Johnston PG
Cancer Res; 2000 Sep; 60(17):4729-34. PubMed ID: 10987277
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
[TBL] [Abstract][Full Text] [Related]
19. Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome.
Gambaro K; Quinn MC; Cáceres-Gorriti KY; Shapiro RS; Provencher D; Rahimi K; Mes-Masson AM; Tonin PN
BMC Cancer; 2015 Mar; 15():135. PubMed ID: 25886299
[TBL] [Abstract][Full Text] [Related]
20. The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.
Sernbo S; Gustavsson E; Brennan DJ; Gallagher WM; Rexhepaj E; Rydnert F; Jirström K; Borrebaeck CA; Ek S
BMC Cancer; 2011 Sep; 11():405. PubMed ID: 21943380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
